Skip to main content
SpringerLink
Log in

Long Term Efficacy and Clinical Safety of Tianeptine in Depressed Alcoholic Patients after Alcohol Withdrawal

  • Original Research Article
  • Published:
Drug Investigation Aims and scope Submit manuscript

Summary

A multicentre study was designed to treat patients presenting with a major depressive episode, single or recurrent, or dysthymic disorder with tianeptine for 1 year. 22% of these patients had a concurrent diagnosis of alcoholism. This intermediate analysis presents results obtained with the first 122 depressed alcoholic patients included, of which 63 were treated for 1 year. The results allow the evaluation of the long term efficacy and tolerability of tianeptine.

The antidepressant activity of tianeptine was confirmed by an almost 50% reduction of initial Montgomery-Asberg depression rating scale scores after 1 month of treatment. Total scores and subscores of the Hamilton anxiety rating scale and Hopkins symptom checklist self-ratings improved concomitantly. Single item and factor scores of the checklist for assessment of somatic symptoms indicated improvement in complaints present at the beginning of the study and an absence of notable adverse effects, particularly of the anticholinergic type. Three patients took massive doses of tianeptine; despite the association with alcohol, these patients did not show marked adverse effects.

These results indicate the potential of tianeptine as an antidepressant in alcoholic patients after withdrawal of alcohol, its long term efficacy, and its good tolerability in patients who are particularly susceptible to the adverse effects of psychotropic drugs. The drug does not provoke orthostatic hypotension or weight change.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed., American Psychiatric Association, Washington, 1980

    Google Scholar 

  • Badawy AAB, Punjany NF, Evans CM, Evans M. Inhibition of rat brain tryptophan metabolism by ethanol withdrawal and possible involvement of the enhanced liver tryptophan pyrrolase activity. Biochemical Journal 192: 449–455, 1980

    PubMed  CAS  Google Scholar 

  • Ballenger JC, Goodwin FK, Major LF, Brown GL. Alcohol and central serotonin metabolism in man. Archives of General Psychiatry 36: 226–227, 1979

    Article  Google Scholar 

  • Davis VE, Brown H, Huff JA, Cashaw JL. The alterations of serotonin metabolism to 5-hydroxytryptophol by ethanol ingestion in man. Journal of Laboratory and Clinical Medicine 69: 132–140, 1967

    PubMed  CAS  Google Scholar 

  • Delalleau B, Dulcire C, Le Moine P, Kamoun A. Analysis of the side effects of tianeptine. Clinical Neuropharmacology 11 (Suppl. 2): S83–S89, 1988

    PubMed  Google Scholar 

  • Defrance R, Marey C, Kamoun A. Antidepressant and anxiolytic activities of tianeptine: an overview of clinical trials. Clinical Neuropharmacology 11 (Suppl. 2): S74–S82, 1988

    PubMed  Google Scholar 

  • Derogatis CR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins symptom checklist (HSCL): a self-report symptom inventory. Behavioural Science 19: 1–15, 1974

    Article  CAS  Google Scholar 

  • Fillion G. Inhibition par la tianeptine de la stimulation de l’adenylcyclase induite par la sérotonine. Journal de Psychiatrie Biologique et Thérapeutique (Suppl.): 30–31, 1989

    Google Scholar 

  • Galinowski A, Olie JP, Guelfi J-D, Malka R, Dulcire C, et al. Interest of long-term antidepressant therapy: experience with tianeptine, a new antidepressant. Abstract. Psychopharmacology 96 (Suppl.): 11, 1988

    Google Scholar 

  • Gay C, Benkelfat C, Renardet M. Utilisation de la télématique dans les essais cliniques de phase IV: une étude nationale avec la trazodone sur 1946 patients déprimés. Actualités Psychiatriques 4: 81–96, 1986

    Google Scholar 

  • Grivois H, Niox H, Kamoun A. Etude contrôlée à double insu de l’intéret thérapeutique de la tianeptine dans les états dépressifs des alcooliques hospitalisés pour cure de sevrage. In Perris et al. (Eds) Proceedings of the 3rd World Congress of Biological Psychiatry, pp. 601–604, Elsevier/North Holland Biomedical Press, Amsterdam, 1981

    Google Scholar 

  • Guelfi JD, Barthelet G, Lancrenon S, Fermanian J. Structure factorielle de la HSCL sur un échantillon de patients anxio-dépressifs français. Annales Medico-Psychologiques 142: 889–898, 1984

    PubMed  CAS  Google Scholar 

  • Guelfi JD, Pichot P, Dreyfus JF. Efficacy of tianeptine in anxious depressed patients: results of a controlled multicentre trial versus amitriptyline. Neuropsychobiology 22: 41–48, 1989

    Article  PubMed  CAS  Google Scholar 

  • Guelfi J, Dreyfus JF, Pull CB. A checklist for the assessment of somatic symptoms (CHESS). 7th World Congress of Psychiatry, Vienna, 1983a

  • Guelfi JD, Pull CB, Guelfi C, Ruschel S, Dreyfus JF. La CHESS utilisation dans la pathologie anxieuse et dépressive: structure factorielle. Annales Medico-Psychologiques 141: 257–277, 1983b

    PubMed  CAS  Google Scholar 

  • Guy W. ECDEU assessment manual for psychopathology, pp. 118–122, US Department of Health Education and Welfare, Washington DC, 1976

    Google Scholar 

  • Hamilton M. The assessment of anxiety states by rating. British Journal of Psychology 32: 50–55, 1959

    Article  CAS  Google Scholar 

  • Hamon M, Bourgoin S, Gozlan H. Effet de la tianeptine sur la libération in vitro de 3H-5 HT et sur les divers types de récepteurs sérotoninergiques dans le système nerveux central chez le rat. Journal de Psychiatrie Biologique et Thérapeutique (Suppl.): 32–35, 1989

    Google Scholar 

  • Kato G, Weitsch AF. Neurochemical profile of tianeptine, a new antidepressant drug. Clinical Neuropharmacology 11 (Suppl. 2): S21–S31, 1988

    Google Scholar 

  • Labrid D, Moleyre J, Poignant JC, Malen C, Mocaër E, et al. Structure-activity relationships of tricyclic antidepressant with special reference to tianeptine. Clinical Neuropharmacology 11 (Suppl. 2): S21–S31, 1988

    PubMed  CAS  Google Scholar 

  • Lejeune F, Poignant JC, Reure H. Etude électrophysiologique de la tianeptine, nouveau stimulant du recaptage de la sérotonine possédant une activité antidépressive. Neurophysiologie Clinique 18: 369–381, 1988

    Article  PubMed  CAS  Google Scholar 

  • Lôo H, Deniker P. Position of tianeptine among antidepressive chemotherapies. Clinical Neuropharmacology 11 (Suppl. 2): S97–S102, 1988a

    PubMed  Google Scholar 

  • Lôo H, Malka R, Defrance R, Barrucand D, Benard JY, et al. Tianeptine and amitriptyline: controlled double blind trial in depressed alcoholic patients. Neuropsychobiology 19: 79–85, 1988b

    Article  PubMed  Google Scholar 

  • Lôo H, Olié JP. Problèmes liés à l’arrêt des antidépresseurs et du lithium. Thérapie 39: 403–410, 1984

    PubMed  Google Scholar 

  • Lôo H, Zarifian E, Kamoun A. Place de la tianeptine parmi les antidépresseurs. In Perris et al. (Eds) Proceedings of the 3rd World Congress of Biological Psychiatry, Elsevier/North Holland Biomedical Press, Amsterdam, 1981

    Google Scholar 

  • Malka R. Role of drug therapies in the treatment of alcoholism: alcohol and anxiety-alcohol and depression. Clinical Neuropharmacology 11 (Suppl. 2): S69–S73, 1988a

    PubMed  Google Scholar 

  • Malka R, Fouquet P, Vachonfrance G. Alcoologie. Masson, ed, 1986

  • Malka R, Lôo H. Place des psychotropes dans la prise en charge des alcooliques. Concours Médical 110: 2453–2457, 1988b

    Google Scholar 

  • Malka R, Lôo H, Defrance R, Ganry H. Intérêt de la tianeptine dans le traitement des syndrômes dépressifs au décours du sevrage alcoolique. Journal de Psychiatrie Biologique et Thérapeutique (Suppl.): 48–51, 1989

    Google Scholar 

  • Mennini T, Mocaër E, Garattini S. Tianeptine, a selective enhancer of serotonin uptake in rat brain. Naunyn Schmiedeberg’s Archives of Pharmacology 336: 478–482, 1987

    PubMed  CAS  Google Scholar 

  • Merikangask R, Leckman JF, Prusoff BA, Pauls DL, Weissman MM. Familial transmission of depression and alcoholism. Archives of General Psychiatry 42: 367–372, 1985

    Article  Google Scholar 

  • Mindham RHS, Howland C, Shepherd M. An evaluation of continuation therapy with tricyclic antidepressants in depressive illness. Psychological Medicine 3: 5–7, 1973

    Article  PubMed  CAS  Google Scholar 

  • Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134: 382–389, 1979

    Article  PubMed  CAS  Google Scholar 

  • Montgomery SA, Dufour H, Brion S, Gailledreau J, Laqueille X, et al. The prophylactic efficacy of fluoxetine in unipolar depression. British Journal of Psychiatry 153 (Suppl. 3): 69–75, 1988

    Google Scholar 

  • Olie JP, Guelfi JD, Malka R, Dulcire C, Kamoun A, et al. Traitement de longue durée par les antidépresseurs: la tianeptine; méthodologie d’une étude au long cours. Encéphale 14: 379–384, 1988

    PubMed  CAS  Google Scholar 

  • Ostaptzeff G. Etude contrôlée à double insu versus imipramine de l’efficacité de la tianeptine dans états dépressifs non psychotiques. In Perris et al. (Eds) Proceedings of the 3rd World Congress of Biological Psychiatry, Elsevier/North Holland Biomedical Press, Amsterdam, 1981

    Google Scholar 

  • O’Sullivan K. Depression and its treatment in alcoholics; a review. Canadian Journal of Psychiatry 23: 379–384, 1984

    Google Scholar 

  • Prien RF. Long term treatment of affective disorders. In Meitzer HY (Ed.) Psychopharmacology: the third generation of progress, pp. 1051–1058, Raven Press, New York, 1987

    Google Scholar 

  • Renaud B, Mocaër E, Weitsch AF, Kato G, Mennini T, et al. Stimulation of serotonin uptake induced by a new antidepressant. Abstract. Pharmacopsychiatry 21: 66, 1988

    Google Scholar 

  • Royer RJ, Albin H, Barrucand D, Salvadori-Failler C, Kamoun A. Pharmacokinetic and metabolic parameters of tianeptine in healthy volunteers and in population with risk factors. Clinical Neuropharmacology 11 (Suppl. 2): S90–S96, 1988

    PubMed  CAS  Google Scholar 

  • Stein MK, Rickels K, Weise C. Maintenance therapy with amitriptyline: a controlled trial. American Journal of Psychiatry 137: 370–371, 1980

    PubMed  CAS  Google Scholar 

  • Viamontes JA. Review of drug effectiveness in the treatment of alcoholism. American Journal of Psychiatry 128: 1570–1571, 1972

    PubMed  CAS  Google Scholar 

  • Weiss C, Gorceix A, Kindynis S, Dimitriu M. Etude contrôlée à double insu versus nomifensine de l’activité et du délai d’action d’un nouvel antidépresseur la tianeptine. In Perris et al. (Eds) Proceedings of the 3rd World Congress of Biological Psychiatry, pp. 593–596, Elsevier/North Holland Biomedical Press, Amsterdam, 1981

    Google Scholar 

  • Weissman MM, Myers JK. Clinical depression in alcoholism. American Journal of Psychiatry 137: 372–373, 1980

    PubMed  CAS  Google Scholar 

  • Weitsch AF, Mocaër E, Kato G. Tianeptine: a new antidepressant which increases serotonin uptake. Abstract, p. 24. 15th Collegium Internationale Neuropsychopharmacologicum Congress, San Juan, 1986

  • Winokur G. Alcoholism and depression in the same family. In Goodwin & Erikson (Eds) Alcoholism and affective disorders: clinical, genetic and biochemical studies, pp. 49–56, SP Medical and Scientific Books, New York, 1979

    Google Scholar 

  • Zarifian E, Lôo H. Les antidépresseurs: aspects biologiques, cliniques et thérapeutiques, Roche (ed.), 1982

Download references

Author information

Authors and Affiliations

  1. Centre Gilbert Raby, Meulan et Institut de Psychiatrie La Rochefoucault, Paris, France

    R. Malka

  2. Hôpital Sainte-Anne, Service Hospitalo-Universitaire de Santé Mentale et de Thérapeutique, Paris, France

    H. Lôo

  3. IRIS, 6 place des Pléiades, 92415, Courbevoie Cédéx, France

    H. Ganry, C. Marey & A. Kamoun

Authors
  1. R. Malka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Lôo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Ganry
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Marey
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Kamoun
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malka, R., Lôo, H., Ganry, H. et al. Long Term Efficacy and Clinical Safety of Tianeptine in Depressed Alcoholic Patients after Alcohol Withdrawal. Drug Invest. 2, 225–234 (1990). https://doi.org/10.1007/BF03259201

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03259201

Keywords

Search

Navigation